SuperworthCollegium Pharmaceutical shares outstanding COLL
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 32.5M
- On a year earlier
- −16.9%
- fewer shares
Collegium Pharmaceutical had 32.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 16.9% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 40.1M | −0% |
| FY2024 | 40.1M | −3% |
| FY2023 | 41.3M | +23% |
| FY2022 | 33.6M | −2% |
| FY2021 | 34.1M | −4% |
| FY2020 | 35.4M | +5% |
| FY2019 | 33.6M | +2% |
| FY2018 | 33M | +1% |
| FY2017 | 32.5M | +20% |
| FY2016 | 27.1M | +32% |
| FY2015 | 20.6M | +2050% |
| FY2014 | 956K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 32.5M | −17% | |
| Q1 FY26 | 40.1M | +22% | |
| Q4 FY25 | 40.1M | −0% | |
| Q3 FY25 | 39.4M | −2% | |
| Q2 FY25 | 39.1M | −3% | |
| Q1 FY25 | 32.8M | −21% | |
| Q4 FY24 | 40.1M | −3% | |
| Q3 FY24 | 40.2M | −5% | |
| Q2 FY24 | 40.4M | −6% | |
| Q1 FY24 | 41.4M | +21% | |
| Q4 FY23 | 41.3M | +23% | |
| Q3 FY23 | 42.1M | +22% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Collegium Pharmaceutical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.